Genomic aberrations at CLL diagnosis that increase the risk of RT include CDKN2A deletion, TP53 disruption, C-MYC activation, trisomy 12 (particularly in the absence of del13q14), and NOTCH1 mutation [38]. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.